SAGE Therapeutics Inc (NASDAQ:SAGE)
| 59.58 Delayed Data As of Jun 09 |  +2.88 / +5.08%Today’s Change | 30.67 Today|||52-Week Range 59.68 | +56.21% Year-to-Date |
Latest SAGE News | Press Releases
No recent news for SAGE Therapeutics Inc.
Today’s Trading
| Previous close | 56.70 |
| Today’s open | 56.86 |
| Day’s range | 56.86 - 59.65 |
| Volume | 23,332 |
| Average volume (3 months) | 516,581 |
| Market cap | $3.0B |
Data as of 4:00pm ET, 06/09/2023
Growth & Valuation
| Earnings growth (last year) | -15.11% |
| Earnings growth (this year) | +12.62% |
| Earnings growth (next 5 years) | +3.58% |
| Revenue growth (last year) | +21.85% |
| P/E ratio | NM |
| Price/Sales | 294.29 |
| Price/Book | 2.36 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| KRYSKrystal Biotech Inc | +0.94 | +0.73% |
| CYTKCytokinetics Inc | -1.02 | -2.68% |
| RETAReata Pharmaceutical... | -0.32 | -0.34% |
| RAREUltragenyx Pharmaceu... | -0.22 | -0.43% |
Data as of 4:00pm ET, 06/09/2023
Financials
| Next reporting date | August 8, 2023 |
| EPS forecast (this quarter) | -$2.57 |
| Annual revenue (last year) | $7.7M |
| Annual profit (last year) | -$532.8M |
| Net profit margin | -6,931.88% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
